| Website | avexxin.com |
| Category | BioTech |
| Phone | +47 73 59 61 07 |
| avexxin@avexxin.com | |
| Employees |
| VENTURE FUNDING | |
| Venture Round, 1/11 Sarsia Seed Management Leiv Eiriksson Invest |
Avexxin’s therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases at the Norwegian University of Science and Technology. Avexxin’s goal is to create a therapeutic company based on the discovery and development of novel therapeutics that address the fundamental mechanisms involved in inflammatory diseases.
